Group 1 - The core point of the article is that Zhenghong Technology (000702) reported a significant decline in pig sales and revenue for December 2025 compared to previous periods [1] Group 2 - In December 2025, the company sold 0.27 million pigs, with sales revenue of 1.3785 million yuan, representing a month-on-month decrease of 32.68% in sales volume and 69.50% in revenue [1] - Year-on-year comparisons show a drastic decline, with sales volume down 91.74% and revenue down 98.11% [1] - For the entire year of 2025, the company sold a total of 114.9 thousand pigs, generating cumulative sales revenue of 153.0862 million yuan, which reflects a year-on-year increase of 7.90% in sales volume but a decrease of 24.35% in revenue [1]

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

Core Viewpoint - Zhenghong Technology (000702) reported a significant decline in pig sales and revenue for December 2025, indicating potential challenges in the company's performance and market conditions [1] Group 1: December 2025 Sales Performance - The company sold 0.27 thousand pigs in December 2025, representing a month-on-month decrease of 32.68% [1] - The sales revenue for December 2025 was 1.3785 million yuan, reflecting a month-on-month decline of 69.50% [1] - Year-on-year comparisons show a drastic reduction in both sales volume and revenue, with decreases of 91.74% and 98.11% respectively [1] Group 2: Annual Sales Performance (2025) - For the entire year of 2025, the company sold a total of 114.9 thousand pigs, which is a year-on-year increase of 7.90% [1] - The cumulative sales revenue for 2025 was 15.3 million yuan, showing a year-on-year decrease of 24.35% [1]

Core Viewpoint - Zhenghong Technology (000702.SZ) reported a significant decline in both sales volume and revenue from live pigs in December 2025 compared to previous periods, indicating potential challenges in the company's performance and market conditions [1]. Sales Performance - In December 2025, the company sold 0.27 thousand live pigs, with sales revenue of 1.3785 million yuan, representing a month-on-month decrease of 32.68% in volume and 69.50% in revenue [1]. - Year-on-year comparisons show a drastic decline, with sales volume down 91.74% and revenue down 98.11% [1]. Annual Performance - For the entire year of 2025, the company sold a total of 114.9 thousand live pigs, generating cumulative sales revenue of 153.0862 million yuan [1]. - The annual sales volume increased by 7.90% year-on-year, while the sales revenue decreased by 24.35% compared to the previous year [1].

证券代码：000702 证券简称： 正虹科技 公告编号：2026—001 湖南正虹科技发展股份有限公司 2025 年 12 月生猪销售简报 公司本月生猪销售同比减少的主要原因是公司生猪出栏量减少所致。 三、风险提示 1、上述披露仅包含公司生猪养殖业务销售情况，不含其它业务。 2、生猪市场价格波动的风险是整个生猪生产行业的系统风险，对任何一家 生猪生产者来说，都是客观存在的、不可控制的外部风险。生猪市场价格的大幅 波动，可能会对公司的经营业绩产生重大影响。 3、上述数据均未经审计，与定期报告披露的数据之间可能存在差异。因此， 上述数据仅作为阶段性数据，供投资者参考。敬请广大投资者注意投资风险。 四、其他提示 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、生猪销售情况 湖南正虹科技发展股份有限公司（以下简称"公司"）2025 年 12 月销售生 猪 0.27 万头，销售收入 137.85 万元，环比变动分别减少 32.68%、69.50%。同 比变动分别减少 91.74%、98.11%。 2025 年 1-12 月份，公司累计销售生猪 11.49 万头，累计 ...

Group 1 - The core point of the article is that Zhenghong Technology (000702.SZ) reported a significant decline in pig sales and revenue for December 2025 [1] Group 2 - In December 2025, the company sold 0.27 thousand pigs, which represents a month-on-month decrease of 32.68% [1] - The sales revenue for December 2025 was 1.3785 million yuan, showing a month-on-month decline of 69.50% [1] - Year-on-year comparisons indicate a drastic reduction, with pig sales down 91.74% and revenue down 98.11% [1]

Core Viewpoint - The company reported a significant decline in both the number of pigs sold and sales revenue for December 2025 compared to previous periods, indicating potential challenges in the market [1] Sales Performance - In December 2025, the company sold 0.27 thousand pigs, with sales revenue of 1.3785 million yuan, reflecting a month-on-month decrease of 32.68% in sales volume and 69.50% in revenue [1] - Year-on-year comparisons show a drastic decline, with sales volume down 91.74% and sales revenue down 98.11% [1] Cumulative Sales Data - For the entire year of 2025, the company sold a total of 114.9 thousand pigs, generating cumulative sales revenue of 15.3 million yuan [1] - The annual sales volume increased by 7.90% compared to the previous year, while sales revenue decreased by 24.35% year-on-year [1]

Market Overview - The feed sector experienced a decline of 1.08% on December 31, with TianKang Biological leading the drop [1] - The Shanghai Composite Index closed at 3968.84, up 0.09%, while the Shenzhen Component Index closed at 13525.02, down 0.58% [1] Individual Stock Performance - JinXinNong (002548) saw a significant increase of 9.95%, closing at 6.08, with a trading volume of 816,900 shares and a transaction value of 479 million [1] - TianKang Biological (002100) declined by 3.03%, closing at 7.37, with a trading volume of 337,500 shares and a transaction value of 250 million [2] - Other notable performers include ZhiYang Co. (002696) with a 1.00% increase, and Boen Group (001366) with a 0.91% increase [1] Capital Flow Analysis - The feed sector experienced a net outflow of 75.87 million from institutional investors, while retail investors saw a net inflow of 22.40 million [2] - JinXinNong had a net inflow of 64.54 million from institutional investors, but a net outflow of 36.08 million from retail investors [3] - TianMa Technology (603668) had a net inflow of 11.83 million from institutional investors, while retail investors experienced a net outflow of 13.32 million [3]

2025 年 12 月 30 日经公司 2025 年第六次临时股东会审议通过 1 | | | | 第二章 | 经营宗旨和范围……………………………………………………………………5 | | --- | --- | | 第三章 | 股 份………………………………………………………………………………5 | | 第四章 | 股东和股东会………………………………………………………………………8 | | 第五章 | 董 事 会 …………………………………………………………………………23 | | 第六章 | 高级管理人员 ……………………………………………………………………36 | | 第七章 | 公司党委…………………………………………………………………………38 | | 第八章 | 财务会计制度、利润分配和审计 ………………………………………………39 | | 第一节 | | 财务会计制度…………………………………………………………………39 | | | --- | --- | --- | --- | | 第二节 | | 内部审计………………………………………………………………………41 | | | 第三节 | | ...

易德玮先生的任职资格符合相关法律法规及《公司章程》有关规定。本次选 举后，公司第十届董事会中兼任公司高级管理人员以及由职工代表担任的董事人 数总计未超过公司董事总数的二分之一，符合相关法律法规的要求。 湖南正虹科技发展股份有限公司 关于选举职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为保障湖南正虹科技发展股份有限公司（以下简称"公司"）董事会正常运 行，进一步优化治理结构，根据《中华人民共和国公司法》《深圳证券交易所上 市公司自律监管指引第 1 号——主板上市公司规范运作》等法律法规和《公司章 程》的规定，并结合实际情况，公司近日召开职工代表大会，经职工代表审议表 决，选举易德玮先生为公司第十届董事会职工代表董事（简历见附件）。易德玮 先生将与公司 2025 年第六次临时股东大会选举产生的非职工代表董事共同组成 公司第十届董事会。 证券代码：000702 证券简称：正虹科技 公告编号：2025-072 附件： 易德玮，男，1974年10月出生，中共党员，硕士学历。2014年12月至2016年 10月任湖南正虹科技发展股份有限公司董事、总 ...